Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Risk of serious infection among individuals with and without low count monoclonal B-cell lymphocytosis (MBL)

Risk of serious infection among individuals with and without low count monoclonal B-cell... Leukemia (2021) 35:239–244 https://doi.org/10.1038/s41375-020-0799-8 LETTER Chronic lymphocytic leukemia Risk of serious infection among individuals with and without low count monoclonal B-cell lymphocytosis (MBL) 1 2 2 2 2 2 ● ● ● ● ● ● Tait D. Shanafelt Neil E. Kay Sameer A. Parikh Sara J. Achenbach Connie E. Lesnick Curtis A. Hanson 2 2 2 2 2 2 ● ● ● ● ● ● Geffen Kleinstern Janet E. Olson Aaron D. Norman Kari G. Rabe Susan M. Schwager Timothy G. Call Susan L. Slager Received: 7 October 2019 / Revised: 27 February 2020 / Accepted: 9 March 2020 / Published online: 18 March 2020 © Springer Nature Limited 2020 To the Editor: the approval of the Mayo Clinic IRB, we screened partici- pating individuals from Olmsted County (the county in Monoclonal B-cell lymphocytosis (MBL), the precursor state which Mayo Clinic is located), Minnesota, who were 40 to chronic lymphocytic leukemia (CLL), is one of the most years of age or older, no prior history of hematologic common premalignant conditions in humans [1, 2]. MBL is malignancy, and who had stored PBMC (samples from subdivided into low count (LC) MBL and high count (HC) 7/14/2009 to 3/4/2016). Data on http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Leukemia Springer Journals

Loading next page...
 
/lp/springer-journals/risk-of-serious-infection-among-individuals-with-and-without-low-count-bZWhTocU7n

References (14)

Publisher
Springer Journals
Copyright
Copyright © Springer Nature Limited 2020
ISSN
0887-6924
eISSN
1476-5551
DOI
10.1038/s41375-020-0799-8
Publisher site
See Article on Publisher Site

Abstract

Leukemia (2021) 35:239–244 https://doi.org/10.1038/s41375-020-0799-8 LETTER Chronic lymphocytic leukemia Risk of serious infection among individuals with and without low count monoclonal B-cell lymphocytosis (MBL) 1 2 2 2 2 2 ● ● ● ● ● ● Tait D. Shanafelt Neil E. Kay Sameer A. Parikh Sara J. Achenbach Connie E. Lesnick Curtis A. Hanson 2 2 2 2 2 2 ● ● ● ● ● ● Geffen Kleinstern Janet E. Olson Aaron D. Norman Kari G. Rabe Susan M. Schwager Timothy G. Call Susan L. Slager Received: 7 October 2019 / Revised: 27 February 2020 / Accepted: 9 March 2020 / Published online: 18 March 2020 © Springer Nature Limited 2020 To the Editor: the approval of the Mayo Clinic IRB, we screened partici- pating individuals from Olmsted County (the county in Monoclonal B-cell lymphocytosis (MBL), the precursor state which Mayo Clinic is located), Minnesota, who were 40 to chronic lymphocytic leukemia (CLL), is one of the most years of age or older, no prior history of hematologic common premalignant conditions in humans [1, 2]. MBL is malignancy, and who had stored PBMC (samples from subdivided into low count (LC) MBL and high count (HC) 7/14/2009 to 3/4/2016). Data on

Journal

LeukemiaSpringer Journals

Published: Mar 18, 2020

There are no references for this article.